Sanara MedTech Inc. (SMTI) shareholders
Close on Nov 18, 2026Market cap $300.72MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BAIRD TRUST Co Joint filing with Baird Financial Corp (8.50%), Baird Financial Group, Inc. (8.50%) | 760,293 | 8.50% | 13G (passive) | Dec 31, 2025 |
| The Goldman Sachs Group, Inc. Joint filing with Goldman Sachs & Co. LLC (5.00%) | 462,021 | 5.00% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SMTI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 248,827 | 2.71% | $5.87M | +20,060 | 0.00% |
| Vanguard Capital Management LLC | 194,897 | 2.12% | $4.60M | +43,530 | 0.00% |
| Royal Bank of Canada | 130,995 | 1.43% | $3.09M | −394 | 0.00% |
| Stonebridge Wealth Management, LLC | 129,452 | 1.41% | $3.05M | −7,447 | 2.73% |
| Aqr Capital Management LLC | 112,207 | 1.22% | $2.65M | +72,269 | 0.00% |
| Geode Capital Management, LLC | 89,179 | 0.97% | $2.10M | +3,517 | 0.00% |
| Goldman Sachs Group Inc | 74,198 | 0.81% | $1.75M | +52,613 | 0.00% |
| Renaissance Technologies LLC | 67,400 | 0.73% | $1.59M | +2,720 | 0.00% |
| State Street Corp | 63,469 | 0.69% | $1.50M | +780 | 0.00% |
| Squarepoint Ops LLC | 53,811 | 0.59% | $1.27M | −19,796 | 0.00% |
| Jane Street Group, LLC | 50,806 | 0.55% | $1.20M | +12,222 | 0.00% |
| Marshall Wace, Llp | 49,457 | 0.54% | $1.17M | −26,825 | 0.00% |
| Citadel Advisors LLC | 36,813 | 0.40% | $868.42K | +5,700 | 0.00% |
| Northern Trust Corp | 36,441 | 0.40% | $859.64K | +3,185 | 0.00% |
| Jacobs Levy Equity Management, Inc | 31,644 | 0.34% | $746.48K | New | 0.00% |
| Walleye Capital LLC | 30,465 | 0.33% | $718.67K | New | 0.00% |
| Los Angeles Capital Management LLC | 26,830 | 0.29% | $632.92K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 26,027 | 0.28% | $613.98K | +652 | 0.00% |
| Evernest Financial Advisors, LLC | 25,700 | 0.28% | $606.26K | New | 0.13% |
| Morgan Stanley | 23,628 | 0.26% | $557.38K | +3,988 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 75 | 2M | 19.4% | 16 / 32 | 15 / 4 | 0M | 0M |
| Q1 2026 | 65 | 1M | 16.2% | 18 / 26 | 14 / 5 | 1M | 1M |
| Q4 2025 | 53 | 2M | 21.2% | 9 / 23 | 13 / 11 | 1M | 0M |
| Q3 2025 | 58 | 1M | 12.5% | 13 / 12 | 22 / 7 | 0M | 0M |
| Q2 2025 | 52 | 1M | 12.4% | 8 / 17 | 19 / 5 | 0M | 0M |
| Q1 2025 | 49 | 1M | 10.0% | 4 / 12 | 20 / 6 | 0M | 0M |
| Q4 2024 | 51 | 1M | 10.4% | 9 / 24 | 5 / 2 | 0M | 0M |
| Q3 2024 | 44 | 1M | 8.9% | 8 / 15 | 10 / 3 | 0M | 0M |
| Q2 2024 | 40 | 1M | 8.0% | 4 / 20 | 10 / 7 | 0M | 0M |
| Q1 2024 | 43 | 1M | 7.6% | 1 / 14 | 20 / 4 | 0M | 0M |
| Q4 2023 | 47 | 1M | 7.6% | 4 / 21 | 13 / 0 | 0M | 0M |
| Q3 2023 | 43 | 1M | 6.9% | 5 / 11 | 15 / 9 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
79 funds held SMTI in Q2 2026, 70% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SMTI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 148,899 | 1.62% | $3.51M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 74,682 | 0.81% | $1.76M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 42,865 | 0.47% | $1.01M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 36,350 | 0.40% | $1.23M | 0.00% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 31,668 | 0.34% | $747.05K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 19,525 | 0.21% | $444.97K | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 15,524 | 0.17% | $353.79K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 11,230 | 0.12% | $264.92K | 0.02% | Jun 30, 2026 |
| U.S. Small Cap Equity Fund | 11,038 | 0.12% | $373.75K | 0.04% | Jul 31, 2026 |
| Goldman Sachs Absolute Return Tracker Fund | 9,609 | 0.10% | $226.68K | 0.00% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 8,345 | 0.09% | $282.56K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 6,529 | 0.07% | $148.80K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 5,716 | 0.06% | $130.27K | 0.00% | May 31, 2026 |
| Master Small Cap Index Series | 5,191 | 0.06% | $122.46K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 5,177 | 0.06% | $117.98K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Seth D. Yon | Chief Executive Officer, Director | 105,885 | 1.15% | Sep 16, 2026 |
| Ashley M. Mackey | Controller | 4,967 | 0.05% | May 5, 2026 |
| Jacob A. Waldrop | Chief Operating Officer | 24,377 | 0.27% | Apr 16, 2026 |
| Elizabeth B. Taylor | Chief Financial Officer | 17,632 | 0.19% | Mar 23, 2026 |
| Michael D. McNeil | Ch. Acct. & Ch. Admin. Officer | 28,587 | 0.31% | Aug 19, 2025 |
| Suresh V. Muppalla | Pres & CEO, Tissue Health Plus | 2,973 | 0.03% | Apr 15, 2025 |
| Robert Andrew DeSutter | Director | 28,740 | 0.31% | Jun 5, 2026 |
| Roszell Mack III | Director | 21,842 | 0.24% | Jun 5, 2026 |
| Eric D. Major | Director | 14,232 | 0.15% | Jun 5, 2026 |
| Keith G. Myers | Director | 9,325 | 0.10% | Jun 5, 2026 |
| Eric D. Tanzberger | Director | 22,966 | 0.25% | Jun 5, 2026 |
| Ronald T. Nixon | Director, 10% owner | 1,032,052 | 11.23% | Jun 5, 2026 |
| Ann Beal Salamone | Director | 26,858 | 0.29% | Jun 5, 2026 |
| Sara N. Ortwein | Director | 25,415 | 0.28% | Jun 5, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Seth D. Yon Chief Executive Officer, Director | Sep 15, 2026 | Tax withholding | −3,661 | $35.11 | $128.54K | 105,885 |
| Ann Beal Salamone Director | Jun 4, 2026 | Award | +4,154 | – | – | 26,858 |
| Keith G. Myers Director | Jun 4, 2026 | Award | +4,385 | – | – | 9,325 |
| Robert Andrew DeSutter Director | Jun 4, 2026 | Award | +5,539 | – | – | 28,740 |
| Eric D. Major Director | Jun 4, 2026 | Award | +4,846 | – | – | 14,232 |
| Roszell Mack III Director | Jun 4, 2026 | Award | +5,308 | – | – | 21,842 |
| Ronald T. Nixon Director, 10% owner | Jun 4, 2026 | Award | +4,154 | – | – | 68,196 |
| Eric D. Tanzberger Director | Jun 4, 2026 | Award | +5,308 | – | – | 22,966 |
| Sara N. Ortwein Director | Jun 4, 2026 | Award | +4,616 | – | – | 25,415 |
| Seth D. Yon Chief Executive Officer, Director | May 15, 2026 | Tax withholding | −3,852 | $21.06 | $81.12K | 109,546 |
| Jacob A. Waldrop Chief Operating Officer | Apr 15, 2026 | Tax withholding | −378 | $20.01 | $7.56K | 24,377 |
| Ashley M. Mackey Controller | Mar 22, 2026 | Award | +2,804 | – | – | 4,967 |
| Ashley M. Mackey Controller | Mar 22, 2026 | Award | −2,804 | – | – | 5,067 |
| Elizabeth B. Taylor Chief Financial Officer | Mar 22, 2026 | Award | −12,687 | – | – | 17,632 |
| Seth D. Yon Chief Executive Officer, Director | Mar 22, 2026 | Award | −25,430 | – | – | 113,398 |
| Jacob A. Waldrop Chief Operating Officer | Mar 22, 2026 | Award | −13,956 | – | – | 24,755 |
| Seth D. Yon Chief Executive Officer, Director | Mar 7, 2026 | Tax withholding | −596 | $18.87 | $11.25K | 87,968 |
| Seth D. Yon Chief Executive Officer, Director | Mar 1, 2026 | Tax withholding | −414 | $20.44 | $8.46K | 88,564 |
| Seth D. Yon Chief Executive Officer, Director | Mar 1, 2026 | Tax withholding | −491 | $20.44 | $10.04K | 88,487 |
| Seth D. Yon Chief Executive Officer, Director | Feb 25, 2026 | Tax withholding | −873 | $19.90 | $17.37K | 88,978 |
| Ashley M. Mackey Controller | Feb 25, 2026 | Tax withholding | −149 | $19.90 | $2.97K | 2,263 |
| Elizabeth B. Taylor Chief Financial Officer | Feb 25, 2026 | Tax withholding | −437 | $19.90 | $8.70K | 4,945 |
| Jacob A. Waldrop Chief Operating Officer | Feb 25, 2026 | Tax withholding | −714 | $19.90 | $14.21K | 10,799 |
| Seth D. Yon Chief Executive Officer | Sep 15, 2025 | Award | +28,563 | – | – | 89,851 |
| Michael D. McNeil Ch. Acct. & Ch. Admin. Officer | Aug 19, 2025 | Tax withholding | −2,324 | $30.86 | $71.72K | 28,587 |
| Eric D. Tanzberger Director | May 22, 2025 | Award | +3,590 | – | – | 17,658 |
| Sara N. Ortwein Director | May 22, 2025 | Award | +3,277 | – | – | 20,799 |
| Keith G. Myers Director | May 22, 2025 | Award | +2,965 | – | – | 4,940 |
| Robert Andrew DeSutter Director | May 22, 2025 | Award | +3,746 | – | – | 23,201 |
| Eric D. Major Director | May 22, 2025 | Award | +3,277 | – | – | 9,386 |
| Ann Beal Salamone Director | May 22, 2025 | Award | +2,809 | – | – | 22,704 |
| Roszell Mack III Director | May 22, 2025 | Award | +3,433 | – | – | 16,534 |
| Seth D. Yon Pres. & Ch. Commercial Officer | May 15, 2025 | Tax withholding | −4,929 | $30.88 | $152.21K | 61,288 |
| Jacob A. Waldrop Chief Operating Officer | Apr 15, 2025 | Tax withholding | −378 | $29.38 | $11.11K | 11,513 |
| Michael D. McNeil Ch. Acct. & Ch. Admin. Officer | Apr 10, 2025 | Tax withholding | −378 | $33.01 | $12.48K | 31,273 |
| Michael D. McNeil Ch. Acct. & Ch. Admin. Officer | Apr 10, 2025 | Tax withholding | −343 | $34.69 | $11.90K | 31,651 |
| Michael D. McNeil Ch. Acct. & Ch. Admin. Officer | Apr 10, 2025 | Tax withholding | −527 | $34.69 | $18.28K | 31,994 |
| Michael D. McNeil Ch. Acct. & Ch. Admin. Officer | Apr 10, 2025 | Tax withholding | −362 | $34.65 | $12.54K | 30,911 |
| Michael D. McNeil Ch. Acct. & Ch. Admin. Officer | Mar 19, 2025 | Award | +1,486 | – | – | 32,521 |
| Elizabeth B. Taylor Chief Financial Officer | Feb 25, 2025 | Award | +5,382 | – | – | 5,382 |
| Ronald T. Nixon Chief Executive Officer, Director, 10% owner | Feb 25, 2025 | Award | +7,534 | – | – | 64,042 |
| Jacob A. Waldrop Chief Operating Officer | Feb 25, 2025 | Award | +8,790 | – | – | 11,891 |
| Michael D. McNeil Ch. Acct. & Ch. Admin Officer | Feb 25, 2025 | Award | +5,037 | – | – | 31,035 |
| Keith G. Myers Director | Nov 11, 2024 | Award | +1,975 | – | – | 1,975 |
| Eric D. Tanzberger Director | Jun 12, 2024 | Award | +3,768 | – | – | 14,068 |
| Ronald T. Nixon Chief Executive Officer, Director, 10% owner | Jun 12, 2024 | Award | +10,812 | – | – | 56,508 |
| James W. Stuckert Director, 10% owner | Jun 12, 2024 | Award | +3,440 | – | – | 840,218 |
| Roszell Mack III Director | Jun 12, 2024 | Award | +3,604 | – | – | 13,101 |
| Ann Beal Salamone Director | Jun 12, 2024 | Award | +2,949 | – | – | 19,895 |
| Sara N. Ortwein Director | Jun 12, 2024 | Award | +3,440 | – | – | 17,522 |
| Robert Andrew DeSutter Director | Jun 12, 2024 | Award | +3,932 | – | – | 19,455 |
| Eric D. Major Director | Jun 12, 2024 | Award | +3,440 | – | – | 6,109 |
| Jacob A. Waldrop Chief Operating Officer | Apr 15, 2024 | Award | +3,101 | – | – | 3,101 |
| Michael D. McNeil Chief Financial Officer | Mar 7, 2024 | Award | +4,650 | – | – | 25,998 |
| Zachary B. Fleming Chief Executive Officer | Mar 7, 2024 | Award | +12,693 | – | – | 48,854 |
| Michael D. McNeil Chief Financial Officer | Mar 1, 2024 | Tax withholding | −687 | $38.96 | $26.77K | 21,947 |
| Michael D. McNeil Chief Financial Officer | Mar 1, 2024 | Tax withholding | −599 | $38.96 | $23.34K | 21,348 |
| Zachary B. Fleming Chief Executive Officer | Mar 1, 2024 | Tax withholding | −926 | $38.96 | $36.08K | 36,951 |
| Zachary B. Fleming Chief Executive Officer | Mar 1, 2024 | Tax withholding | −790 | $38.96 | $30.78K | 36,161 |
| Zachary B. Fleming Chief Executive Officer | Feb 1, 2024 | Tax withholding | −427 | $33.72 | $14.40K | 37,877 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sanara MedTech's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,955 shares on Aug 31, 2026 over the last 90 days.
See a number that looks wrong?